Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammed Kallash

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cardiology in Review|February 3, 2025
Investigating the Relationship Between Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and Blood PressureMohammed Kallash, William Frishman
Cardiology in Review|February 4, 2025
Cardiovascular SyphilisMohammed Kallash, William Frishman
Cardiology in Review|February 3, 2025
Continuation Versus Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Undergoing Noncardiac SurgeryMohammed Kallash, William Frishman
Cardiology in Review|December 16, 2024
Right Ventricular Myocardial InfarctionsMohammed Kallash, William Frishman
Cardiology in Review|March 26, 2025
Tongxinluo, a Chinese Medicine Compound With Cardiovascular BenefitsMohammed Kallash, William H Frishman
Cardiology in Review|March 26, 2025
Investigating the Physiologic Role of Leptin and Its Relationship to ObesityMohammed Kallash, William H Frishman
Cardiology in Review|June 20, 2025
Vericiguat, a Soluble Guanylate Cyclase Stimulator Approved for Heart Failure TreatmentMohammed Kallash, William H Frishman
Cardiology in Review|July 1, 2025
Transthyretin Amyloid Cardiomyopathy: A Review of Approved PharmacotherapiesMohammed Kallash, William H Frishman
Cardiology in Review|February 6, 2025
Trimetazidine Use in Cardiovascular DiseaseMohammed Kallash, William H Frishman
Cardiology in Review|February 18, 2026
Subcutaneous Furosemide, a Novel Therapy With Potential to Reduce Heart Failure BurdenMohammed Kallash, William H Frishman
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cardiology in Review|February 3, 2025
Investigating the Relationship Between Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and Blood PressureMohammed Kallash, William Frishman
Cardiology in Review|February 4, 2025
Cardiovascular SyphilisMohammed Kallash, William Frishman
Cardiology in Review|February 3, 2025
Continuation Versus Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Undergoing Noncardiac SurgeryMohammed Kallash, William Frishman
Cardiology in Review|December 16, 2024
Right Ventricular Myocardial InfarctionsMohammed Kallash, William Frishman
Cardiology in Review|March 26, 2025
Tongxinluo, a Chinese Medicine Compound With Cardiovascular BenefitsMohammed Kallash, William H Frishman
Cardiology in Review|March 26, 2025
Investigating the Physiologic Role of Leptin and Its Relationship to ObesityMohammed Kallash, William H Frishman
Cardiology in Review|June 20, 2025
Vericiguat, a Soluble Guanylate Cyclase Stimulator Approved for Heart Failure TreatmentMohammed Kallash, William H Frishman
Cardiology in Review|July 1, 2025
Transthyretin Amyloid Cardiomyopathy: A Review of Approved PharmacotherapiesMohammed Kallash, William H Frishman
Cardiology in Review|February 6, 2025
Trimetazidine Use in Cardiovascular DiseaseMohammed Kallash, William H Frishman
Cardiology in Review|February 18, 2026
Subcutaneous Furosemide, a Novel Therapy With Potential to Reduce Heart Failure BurdenMohammed Kallash, William H Frishman
Pageof 2